tirzepatide december 19 US judge sides with FDA's removal of Lilly's weight loss drug from shortage list Tirzepatide isn't about shortcuts: it's

Dysfunction of the iron storage protein also affected cellular iron homeostasis in the enterocytes

Current law blocks Medicare weight-loss drug coverage Policy changes expected mid-2026 Medicaid coverage remains state-dependent What This Means for You Check your specific plan: Self-funded employers can still choose to cover Zepbound During open enrollment: Ask HR about 2026 GLP-1 coverage changes Consider alternatives: Wegovy is covered on most Aetna plans with similar efficacy Self-pay options: TrumpRx ($346/month), LillyDirect ($299-$449/month), or Foundayo (~$149/month oral GLP-1)

Multi-month discounts (injectable semaglutide): 3-month plan at ~$209/mo effective 6-month at ~$191/mo 12-month at ~$174/mo

But adaptation is not guaranteed